AAPL 169.02 1.2702% MSFT 409.06 0.3656% GOOG 161.1 0.7379% GOOGL 159.13 0.5497% AMZN 176.59 -1.6431% NVDA 796.77 -3.3316% META 493.5 -0.5241% TSLA 162.13 12.0611% TSM 132.97 -0.3448% LLY 732.2 -1.8091% V 275.02 0.332% AVGO 1256.82 0.6108% JPM 193.08 0.4892% UNH 487.3 0.2304% NVO 126.16 -1.9279% WMT 59.87 1.32% LVMUY 171.62 -0.1106% XOM 121.05 0.0165% LVMHF 859.75 -0.3073% MA 462.5 -0.0691%
Last update at 2024-04-24T20:00:00Z
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -152.00900M | -144.16200M | -78.84900M | -57.14100M | -30.16900M |
| Minority interest | - | - | - | - | - |
| Net income | -152.14900M | -144.32600M | -78.99400M | -56.90200M | -28.97500M |
| Selling general administrative | 300.01M | 229.27M | 129.16M | 101.71M | 72.51M |
| Selling and marketing expenses | - | - | - | - | 72.51M |
| Gross profit | 233.06M | 157.76M | 102.50M | 77.59M | 63.24M |
| Reconciled depreciation | 43.93M | 30.17M | 11.63M | 8.51M | 6.79M |
| Ebit | -121.10200M | -108.87200M | -46.08800M | -38.66700M | -19.99400M |
| Ebitda | -110.51600M | -105.08700M | -45.40000M | -29.36000M | -19.25600M |
| Depreciation and amortization | 10.59M | 3.79M | 0.69M | 9.31M | 0.74M |
| Non operating income net other | - | - | - | -9.86500M | -0.59000M |
| Operating income | -121.10200M | -108.87200M | -46.08800M | -38.66700M | -22.44000M |
| Other operating expenses | 471.97M | 352.08M | 190.95M | 152.09M | 111.69M |
| Interest expense | 5.50M | 7.11M | 12.37M | 27.18M | 7.14M |
| Tax provision | 0.14M | 0.16M | 0.14M | -0.23900M | -1.36100M |
| Interest income | - | - | - | 9.87M | 7.14M |
| Net interest income | -5.50500M | -7.10800M | -12.37400M | - | -7.13900M |
| Extraordinary items | - | - | - | -0.10000M | -0.16700M |
| Non recurring | - | 8.06M | 4.22M | 0.06M | 2.45M |
| Other items | - | - | - | - | - |
| Income tax expense | 0.14M | 0.16M | 0.14M | -0.23900M | -1.36100M |
| Total revenue | 350.87M | 243.21M | 144.86M | 113.43M | 91.69M |
| Total operating expenses | 354.16M | 266.63M | 148.59M | 116.26M | 83.23M |
| Cost of revenue | 117.81M | 85.45M | 42.36M | 35.83M | 28.46M |
| Total other income expense net | -30.90700M | -35.29000M | -32.76100M | -18.47400M | -3.03600M |
| Discontinued operations | - | - | - | -0.10000M | -0.16700M |
| Net income from continuing ops | -152.14900M | -144.32600M | -78.99400M | -56.90200M | -28.80800M |
| Net income applicable to common shares | -152.14900M | -144.32600M | -78.99400M | -57.00200M | -42.46300M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 513.38M | 572.05M | 261.22M | 169.95M | 129.48M |
| Intangible assets | 82.78M | 85.27M | 24.72M | 25.61M | 26.41M |
| Earning assets | - | - | - | - | - |
| Other current assets | 9.36M | 10.31M | 5.44M | 9.88M | 2.38M |
| Total liab | 550.09M | 492.63M | 131.34M | 126.32M | 111.90M |
| Total stockholder equity | -36.71300M | 79.42M | 129.88M | 43.63M | 17.57M |
| Deferred long term liab | 1.30M | - | - | - | - |
| Other current liab | 72.38M | 55.55M | 0.40M | 0.40M | 22.94M |
| Common stock | 0.01M | 0.01000M | 0.00800M | 0.00600M | 0.00400M |
| Capital stock | 0.01M | 0.01000M | 0.00800M | 0.00600M | 0.00400M |
| Retained earnings | -934.47400M | -782.32500M | -637.99900M | -558.92400M | -501.92200M |
| Other liab | 11.54M | 367.93M | 8.63M | 11.95M | 15.39M |
| Good will | 39.77M | 39.69M | 13.90M | 13.90M | 13.90M |
| Other assets | 4.87M | 3.25M | 1.78M | 0.55M | 0.40M |
| Cash | 84.70M | 187.25M | 107.77M | 47.11M | 29.05M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 138.87M | 101.09M | 58.31M | 36.39M | 30.61M |
| Current deferred revenue | 11.96M | 15.26M | 35.23M | 26.42M | -0.00300M |
| Net debt | 311.17M | -182.69400M | -102.68000M | -45.31000M | -25.77800M |
| Short term debt | 19.79M | 4.55M | 5.08M | 1.80M | 3.28M |
| Short long term debt | 14.95M | 0.34M | 4.20M | 0.49M | 3.28M |
| Short long term debt total | 395.86M | 4.55M | 5.08M | 1.80M | 3.28M |
| Other stockholder equity | 884.84M | 844.13M | 743.06M | 577.86M | 494.82M |
| Property plant equipment | 130.31M | 112.68M | 36.67M | 19.72M | 13.23M |
| Total current assets | 255.63M | 331.16M | 184.16M | 108.32M | 75.54M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | -159.26900M | -45.54100M | 114.91M | 28.66M | 0.87M |
| Short term investments | - | - | - | - | - |
| Net receivables | 60.06M | 41.89M | 24.60M | 16.15M | 15.10M |
| Long term debt | 349.51M | 326.49M | 38.03M | 53.45M | 42.30M |
| Inventory | 101.52M | 91.70M | 46.00M | 34.85M | 28.77M |
| Accounts payable | 34.74M | 25.74M | 17.60M | 7.77M | 4.40M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -10.69000M | -5.99400M | 1.20M | 1.09M | 1.06M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 0.01000M | 0.00800M | 0.00600M | 0.00400M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | -782.32500M | -637.99900M | -558.92400M | -501.92200M |
| Treasury stock | - | -25.09700M | -0.09700M | -0.09700M | -0.09700M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 4.87M | 3.25M | 0.60M | 0.55M | 0.40M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 257.74M | 240.90M | 77.06M | 61.63M | 53.94M |
| Capital lease obligations | 31.40M | 28.59M | 0.93M | 2.24M | - |
| Long term debt total | - | 326.49M | 38.03M | 53.45M | 42.30M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -58.28000M | -3.00000M | -23.85900M | -13.03200M | -21.66900M |
| Change to liabilities | 7.52M | 12.59M | 14.02M | 8.25M | -2.67400M |
| Total cashflows from investing activities | -58.28000M | -157.76200M | -23.85900M | -13.03200M | -21.66900M |
| Net borrowings | 35.00M | 306.22M | 19.79M | 8.36M | 1.98M |
| Total cash from financing activities | 31.23M | 311.97M | 130.83M | 64.18M | 53.88M |
| Change to operating activities | 8.93M | 13.25M | 2.59M | 1.63M | -3.04800M |
| Net income | -152.14900M | -144.32600M | -78.99400M | -57.00200M | -28.97500M |
| Change in cash | -102.55200M | 79.48M | 60.65M | 18.06M | 6.59M |
| Begin period cash flow | 187.25M | 107.77M | 47.11M | 29.05M | 22.47M |
| End period cash flow | 84.70M | 187.25M | 107.77M | 47.11M | 29.05M |
| Total cash from operating activities | -75.14300M | -73.43200M | -46.41200M | -33.12100M | -25.60800M |
| Issuance of capital stock | 0.00000M | 131.83M | 111.04M | 55.83M | 51.90M |
| Depreciation | 43.93M | 30.17M | 11.63M | 8.51M | 6.79M |
| Other cashflows from investing activities | - | -86.21800M | -0.72800M | -2.98800M | -15.15500M |
| Dividends paid | - | -316.25000M | - | - | - |
| Change to inventory | -20.70400M | -27.74600M | -18.19200M | -14.71200M | -6.02400M |
| Change to account receivables | -18.83200M | -10.14100M | -7.48400M | -1.29800M | -0.39600M |
| Sale purchase of stock | -3.04100M | -30.96300M | 111.04M | 55.83M | 51.90M |
| Other cashflows from financing activities | 61.77M | 572.35M | 76.46M | 124.41M | 124.54M |
| Change to netincome | 54.13M | 59.88M | 31.51M | 21.80M | -1.29300M |
| Capital expenditures | 58.28M | 68.54M | 23.89M | 13.03M | 6.91M |
| Change receivables | - | -10.14100M | -7.48400M | -1.29800M | -0.39600M |
| Cash flows other operating | - | 7.69M | -2.19100M | -1.44600M | 4.88M |
| Exchange rate changes | - | -1.28900M | 0.09M | 0.03M | -0.02000M |
| Cash and cash equivalents changes | - | 79.48M | 60.65M | 18.06M | 6.59M |
| Change in working capital | -23.08900M | -23.87600M | -15.95300M | -8.37800M | -9.71300M |
| Stock based compensation | 40.56M | 36.45M | 17.66M | 10.96M | 5.30M |
| Other non cash items | 15.61M | 4.59M | 19.23M | 13.23M | 2.39M |
| Free cash flow | -133.42300M | -141.97600M | -70.29800M | -46.15300M | -32.52200M |
Sector: Healthcare Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ATEC Alphatec Holdings Inc |
-0.19 1.47% | 12.74 | - | - | 4.39 | 91.76 | 5.66 | -22.5378 |
| ABT Abbott Laboratories |
-0.7 0.65% | 106.89 | 37.15 | 23.15 | 4.67 | 4.97 | 4.88 | 19.38 |
| SYK Stryker Corporation |
1.94 0.58% | 336.85 | 44.07 | 24.94 | 5.51 | 6.12 | 6.05 | 25.73 |
| MDT Medtronic PLC |
-0.91 1.12% | 80.38 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| BSX Boston Scientific Corp |
3.92 5.68% | 72.91 | 68.17 | 24.57 | 5.85 | 4.26 | 6.46 | 26.80 |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
1950 Camino Vida Roble, Carlsbad, CA, United States, 92008
| Name | Title | Year Born |
|---|---|---|
| Mr. Patrick S. Miles | Exec. Chairman, CEO & Pres | 1966 |
| Mr. J. Todd Koning | Exec. VP & CFO | 1973 |
| Mr. Craig E. Hunsaker | Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel | 1964 |
| Mr. Brian R. Snider | Exec. VP of Marketing | 1978 |
| Mr. David P. Sponsel | Exec. VP of Sales | 1979 |
| Mr. Jonathan Allen | Exec. VP of Commercial Operations | 1960 |
| Mr. Scott Lish | Sr. VP of R&D | 1982 |
| Dr. Luiz Pimenta | Chief Medical Officer | NA |
| Ms. Kelli Mari Howell | Exec. VP of Clinical Strategies | 1974 |
| Mr. Eric Dasso | Exec. VP of Adjunctive Technologies | 1974 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
US 
AU
UK
CA
NZ
Please wait processing your request...